Saneca Pharmaceuticals made a net profit of EUR -3.60 mil with revenues of EUR 57.5 mil in 2019, up by 0% and up by 60.6%, respectively, compared to the previous year. This translates into a net margin of -6.26%.
Historically, between 2014 - 2019, the firm’s net profit reached a high of EUR 6.60 mil in 2014 and a low of EUR -3.60 mil in 2019. Since 2014, the firm's net profit has decreased 155% or % a year on average.
On the operating level, EBITDA reached EUR -1.67 mil, down 195% compared to the previous year. Over the last five years, company's EBITDA has risen 0% a year on average.
You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
